{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:15:48Z","timestamp":1769598948459,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nmd.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:07:48Z","timestamp":1558613268000},"page":"543-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble"],"prefix":"10.1016","volume":"29","author":[{"given":"Jantima","family":"Tanboon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oranee","family":"Sanmaneechai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirirat","family":"Charuvanij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tumtip","family":"Sangruchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeles S.","family":"Galindo-Feria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Ohnuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2019.05.007_bib0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.nmd.2019.05.007_bib0002","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.nmd.2019.05.007_bib0003","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","article-title":"Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies","volume":"56","author":"Liang","year":"2017","journal-title":"Rheumatol (Oxf)"},{"issue":"6","key":"10.1016\/j.nmd.2019.05.007_bib0004","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/mus.25567","article-title":"Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child","volume":"56","author":"Mohassel","year":"2017","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2019.05.007_bib0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/mus.25575","article-title":"Childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies","volume":"56","author":"Zhao","year":"2017","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.nmd.2019.05.007_bib0006","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5692\/clinicalneurol.cn-001040","article-title":"Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: a case study","volume":"57","author":"Hama","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"issue":"2","key":"10.1016\/j.nmd.2019.05.007_bib0007","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2011.04.009","article-title":"Anti-signal recognition particle myopathy in the first decade of life","volume":"45","author":"Suzuki","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2019.05.007_bib0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12969-017-0205-x","article-title":"Effective induction therapy for anti-SRP associated myositis in childhood: a small case series and review of the literature","volume":"15","author":"Binns","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.nmd.2019.05.007_bib0009","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3899\/jrheum.160871","article-title":"Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients","volume":"44","author":"Tansley","year":"2017","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.nmd.2019.05.007_bib0010","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/acr.23113","article-title":"Association of anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies with drb1*07:01 and severe myositis in juvenile myositis patients","volume":"69","author":"Kishi","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.nmd.2019.05.007_bib0011","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1212\/NXI.0000000000000172","article-title":"Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease","volume":"2","author":"Mammen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.nmd.2019.05.007_bib0012","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/CND.0000000000000115","article-title":"Chronic myopathy associated with anti-signal recognition particle antibodies can be misdiagnosed as facioscapulohumeral muscular dystrophy","volume":"17","author":"Ikeda","year":"2016","journal-title":"J Clin Neuromuscul Dis"},{"issue":"4","key":"10.1016\/j.nmd.2019.05.007_bib0013","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/MD.0000000000000416","article-title":"Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan","volume":"94","author":"Watanabe","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.nmd.2019.05.007_bib0014","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1172\/JCI81031","article-title":"Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies","volume":"125","author":"Albrecht","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.nmd.2019.05.007_bib0015","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/ken325","article-title":"Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies","volume":"47","author":"Suzuki","year":"2008","journal-title":"Rheumatol (Oxf)"},{"issue":"10","key":"10.1016\/j.nmd.2019.05.007_bib0016","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/WNL.0b013e3182a35285","article-title":"Diagnostic challenge and therapeutic dilemma in necrotizing myopathy","volume":"81","author":"Claeys","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2019.05.007_bib0017","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s00415-005-0683-5","article-title":"High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders","volume":"252","author":"Hengstman","year":"2005","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2019.05.007_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JND-170282","article-title":"Anti-HMGCR Myopathy","volume":"5","author":"Mohassel","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.nmd.2019.05.007_bib0019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2014.02.002","article-title":"199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands","volume":"24","author":"Bertrand","year":"2014","journal-title":"Neuromuscul Disord."},{"issue":"22","key":"10.1016\/j.nmd.2019.05.007_bib0020","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1212\/WNL.0b013e31823a0ebe","article-title":"Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy","volume":"77","author":"Selcen","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nmd.2019.05.007_bib0021","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.22.8.829","article-title":"Reducing body myopathy","volume":"22","author":"Brooke","year":"1972","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2019.05.007_bib0022","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jnnp-2014-309009","article-title":"Necklace cytoplasmic bodies in hereditary myopathy with early respiratory failure","volume":"86","author":"Uruha","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.nmd.2019.05.007_bib0023","first-page":"904","article-title":"Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy","volume":"118","author":"Schessl","year":"2008","journal-title":"J Clin Invest"},{"issue":"Pt 2","key":"10.1016\/j.nmd.2019.05.007_bib0024","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/brain\/awn325","article-title":"Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1","volume":"132","author":"Schessl","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nmd.2019.05.007_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/mus.23500","article-title":"Novel FHL1 mutation in a family with reducing body myopathy","volume":"47","author":"Schreckenbach","year":"2013","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.nmd.2019.05.007_bib0026","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/NEN.0b013e3182a23506","article-title":"Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders","volume":"72","author":"Malfatti","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Database issue","key":"10.1016\/j.nmd.2019.05.007_bib0027","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonz\u00e1lez-Galarza","year":"2015","journal-title":"Nucleic Acids Res"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619302640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619302640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:07:58Z","timestamp":1760774878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896619302640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0960896619302640"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.05.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}